These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 21094898

  • 21. The entero-insular axis in type 2 diabetes--incretins as therapeutic agents.
    Creutzfeldt W.
    Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S288-303. PubMed ID: 11460578
    [Abstract] [Full Text] [Related]

  • 22. Dietary effects on incretin hormone secretion.
    Wu T, Rayner CK, Jones K, Horowitz M.
    Vitam Horm; 2010; 84():81-110. PubMed ID: 21094897
    [Abstract] [Full Text] [Related]

  • 23. Insulin modulates glucose-dependent insulinotropic polypeptide (GIP) secretion from enteroendocrine K cells in rats.
    Irwin N, Francis JM, Flatt PR.
    Biol Chem; 2011 Oct; 392(10):909-18. PubMed ID: 21851286
    [Abstract] [Full Text] [Related]

  • 24. Free fatty acid receptor GPR120 is highly expressed in enteroendocrine K cells of the upper small intestine and has a critical role in GIP secretion after fat ingestion.
    Iwasaki K, Harada N, Sasaki K, Yamane S, Iida K, Suzuki K, Hamasaki A, Nasteska D, Shibue K, Joo E, Harada T, Hashimoto T, Asakawa Y, Hirasawa A, Inagaki N.
    Endocrinology; 2015 Mar; 156(3):837-46. PubMed ID: 25535828
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. KATP channel as well as SGLT1 participates in GIP secretion in the diabetic state.
    Ogata H, Seino Y, Harada N, Iida A, Suzuki K, Izumoto T, Ishikawa K, Uenishi E, Ozaki N, Hayashi Y, Miki T, Inagaki N, Tsunekawa S, Hamada Y, Seino S, Oiso Y.
    J Endocrinol; 2014 Aug; 222(2):191-200. PubMed ID: 24891433
    [Abstract] [Full Text] [Related]

  • 29. Nesfatin-1 stimulates glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide secretion from STC-1 cells in vitro.
    Ramesh N, Mortazavi S, Unniappan S.
    Biochem Biophys Res Commun; 2015 Jun 26; 462(2):124-30. PubMed ID: 25930999
    [Abstract] [Full Text] [Related]

  • 30. Targeted ablation of glucose-dependent insulinotropic polypeptide-producing cells in transgenic mice reduces obesity and insulin resistance induced by a high fat diet.
    Althage MC, Ford EL, Wang S, Tso P, Polonsky KS, Wice BM.
    J Biol Chem; 2008 Jun 27; 283(26):18365-76. PubMed ID: 18420580
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Discovery of gastric inhibitory polypeptide and its subsequent fate: Personal reflections.
    Pederson RA, McIntosh CH.
    J Diabetes Investig; 2016 Apr 27; 7 Suppl 1(Suppl 1):4-7. PubMed ID: 27186348
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Glucose-dependent insulinotropic polypeptide is required for moderate high-fat diet- but not high-carbohydrate diet-induced weight gain.
    Maekawa R, Ogata H, Murase M, Harada N, Suzuki K, Joo E, Sankoda A, Iida A, Izumoto T, Tsunekawa S, Hamada Y, Oiso Y, Inagaki N, Arima H, Hayashi Y, Seino Y.
    Am J Physiol Endocrinol Metab; 2018 Jun 01; 314(6):E572-E583. PubMed ID: 29406782
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.